Synthesis of novel spin-labeled podophyllotoxin derivatives as potential antineoplastic agents: Part XXV

Medicinal Chemistry Research

Volumn 23, Issue 11, 2014, Pages 4926-4931

  Yang, Liu ^a   Nan, Xiang ^b   Li, Wen Qun ^b   Wang, Mei Juan ^b   Zhao, Xiao Bo ^b   Liu, Ying Qian ^b   Zhang, Zhi Jun ^b   Lee, Kuo Hsiung ^c  

^a LANZHOU JIAOTONG UNIVERSITY   (China)

^b LANZHOU UNIVERSITY   (China)

^c University of North Carolina at Chapel Hill   (United States)

Author keywords

Click chemistry; Cytotoxic activity; Podophyllotoxin; Spin labeled

Indexed keywords

EID: 84930626244     PISSN: 10542523     EISSN: 15548120     Source Type: Journal    
DOI: 10.1007/s00044-014-1042-9     Document Type: Article

References (28)

1. Bhat BA, Reddy PB, Agrawal SK, Saxena AK, Sampath KHM, Qazi GN (2008) Studies on novel 4β-[(4-substituted)-1,2,3-triazol-1-yl]podophyllotoxins as potential anticancer agents. Eur J Med Chem 43:2067-2072
2. Canela C, Moraesb RM, Dayana FE, Ferreira D (2000) Podophyllotoxin. Phytochemistry 54(115-120):12
3. Canetta R, Hilgard P, Florentine S, Bedogni P, Lenaz L (1982) Current development of podophyllotoxins. Cancer Chemother Pharmacol 7:93-98
4. Chen H, Zuo S, Wang XC, Tang XW, Zhao M, Lu YL, Chen LT, Liu J, Liu YF, Liu DL, Zhang S, Li T (2011) Synthesis of 4β-triazole-podophyllotoxin derivatives by azide alkyne cycloaddition and biological evaluation as potential antitumor agents. Eur J Med Chem 46:4709-4714
5. Chen J, Ma L, Zhang R, Tang J, Lai H, Wang J, Wang G, Xu Q, Chen T, Peng F, Qiu J, Liang X, Cao D, Ran Y, Peng A, Wei Y, Chen L (2012) Semi-synthesis and biological evaluation of 1,2,3-triazole-based podophyllotoxin congeners as potent antitumor agents inducing apoptosis in HepG2 cells. Arch Pharm Chem Life Sci 345:945-956
6. Cho SJ, Tropsha A, Suffness M, Cheng YC, Lee KH (1996) Three-dimensional quantitative structure-activity relationship study of 4′-O-demethyl-epipodophyllotoxin analogs using the modified CoMFA/q2-GRS approach. J Med Chem 39:1383-1395
7. Cragg GM, Newman DJ (2004) A Tale of two tumor targets: topoisomerase I and tubulin. The Wall and Wani contribution to cancer chemotherapy. J Nat Prod 67:232-244
8. Garcia ES, Azambuja P (2004) Podoplhyllotoxin: distribution, sources, applications and new cytotoxic derivatives. Toxicon 44:431-459
9. Hankovszky HO, Hideg K, Lex L (1979) Synthesis 1:530-531
10. Imbert T (1998) Discovery of podophyllotoxins. Biochimie 84: 207-222
11. Jardine I (1980) In: Cassady JM, Douros J (eds) Anticancer agent based on natural product models. Academic Press, New York, pp 319-351
12. Jin Y, Chen SW, Tian X (2006) Synthesis and biological evaluation of new spin-labeled derivatives of podophyllotoxin. Bioorg Med Chem 14:3062-3068
13. Joel S (1996) The clinical pharmacology of etoposide. An update. Cancer Treatment Rev 22:179-221
14. Kolb HC, Sharpless KB (2003) The growing impact of click chemistry on drug discovery. Drug Discov Today 8:1128-1137
15. Lee KH (1999) Novel antitumor agents from higher plants. Med Res Rev 19:569-596
16. Liu YQ, Tian X (2005) Synthesis of novel spin-labeled derivatives of podophyllotoxin as potential antineoplastic agents. Synth Commun 35:2749-2758
17. Liu SY, Hwang BD, Haruna M, Imakura Y, Lee KH, Cheng YC (1989) Podophyllotoxin analogs: effects on DNA topoisomerase II, tubulin polymerization, human tumor KB cells, and their VP-16-resistant variants. Mol Pharmacol 36:78-82
18. Liu YQ, Liu YQ, Tian X, Yang L (2008) Synthesis of novel derivatives of bispodophyllotoxin as potential antineoplastic agents - part XVI. Nat Prod Res 22:285-291
19. Liu YQ, Ohkoshi E, Li LH, Yang L, Lee KH (2012) Design, synthesis and cytotoxic activity of novel spin-labeled rotenone derivatives. Bioorg Med Chem Lett 22:920-923
20. Reddy PB, Agrawal SK, Singh S, Bhat BA, Saxena AK, Sampath KHM, Qazi GN (2008a) Synthesis and biological evaluation of 4β-[(4-substituted)-1,2,3-triazol-1-yl]podophyllotoxins as potential anticancer agents. Chem Biodiver 5:1792-1802
21. Reddy PB, Paul DV, Agrawal SK, Saxena AK, Sampath KHM, Qazi GN (2008b) Design, synthesis, and biological testing of 4β-[(4-substituted)-1,2,3-triazol-1-yl] podophyllotoxin analogues as antitumor agents. Arch Pharm Chem Life Sci 341:126-131
22. Reddy DM, Srinivas J, Chashoo G, Saxena AK, Sampath KHM (2011) 4β-[(4-Alkyl)-1,2,3-triazol-1-yl]podophyllotoxins as anticancer compounds: design, synthesis and biological evaluation. Eur J Med Chem 46:1983-1991
23. Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, Warren JT, Bokesch H, Kenney S, Boyd MR (1990) New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 82:1107-1112
24. Stahelin H, von Wartburg A (1989) From podophyllotoxin glucoside to etoposide. Prog Drug Res 33:169-267
25. Tian X, Wang YG, Yang MG, Chen YZ (1997) Synthesis and antitumor activity of spin labeled derivatives of podophyllotoxin. Life Sci 60:511-517
26. Tian X, Zhang FM, Li WG (2002) Antitumor and antioxidant activity of spin labeled derivatives of podophyllotoxin (GP-1) and congeners. Life Sci 70:2433-2443
27. Wang JZ, Tian X, Tsumura H, Shimura K, Ito H (1993) Antitumor activity of a new low immunosuppressive derivative of podophyllotoxin (GP-11)and its mechanisms. Anti-Cancer Drug Des 8:193-205
28. Zhang ZW, Zhang JQ, Hui L, Chen SW, Tian X (2010) First synthesis and biological evaluation of novel spin-labeled derivatives of deoxypodophyllotoxin. Europ J Med Chem 45:1673-1677